Ann: Imugene HER-Vaxx Phase 2 PFS Data and Flags Three New Trials, page-187

."......As far as efficacy is concerned, it is still a bit up in the air. But so far, it is comparable to Herceptin ......

Not cross promoting however for my money a not dissimilar event occurred a while back over at the other well known Lag-3 crowd. Anticipation and promotion of expected positive outcomes were built in. The results for the actual product were OK however, unexpectedly the placebo effect was higher than normal so end result was adjudged to be OK but not great so Mr market slammed the SP. All part of the game I am afraid. Market is very short term orientated at the moment and basically expects all news to be good or simply votes with their fingers. Personally still very happy to sit and wait.